N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamate receptors that play an essential role in mediating excitatory neurotransmission in the mammalian central nervous system (CNS). Functional NMDARs are tetramers composed of GluN1, GluN2A-D, and/or GluN3A-B subunits, giving rise to a wide variety of NMDAR subtypes with unique functional properties. Here, we examined the surface delivery and functional properties of NMDARs containing mutations in the glycine-binding sites in GluN1 and GluN3A subunits expressed in mammalian cell lines and primary rat hippocampal neurons. We found that the structural features of the glycine-binding sites in both GluN1 and GluN3A subunits are correlated with receptor forward trafficking to the cell surface. In addition, we found that a potentially clinically relevant mutation in the glycine-binding site of the human GluN3A subunit significantly reduces surface delivery of NMDARs. Taken together, these findings provide novel insight into how NMDARs are regulated by their glycine-binding sites and may provide important information regarding the role of NMDARs in both physiological and pathophysiological processes in the mammalian CNS.

Department of Physiology Faculty of Science Charles University Prague Albertov 6 12843 Prague 2 Czech Republic

Institute of Experimental Medicine of the Czech Academy of Sciences Videnska 1083 14220 Prague 4 Czech Republic

Institute of Physiology of the Czech Academy of Sciences Videnska 1083 14220 Prague 4 Czech Republic

Zobrazit více v PubMed

Perez-Otano, I., Larsen, R. S. & Wesseling, J. F. Emerging roles of GluN3-containing NMDA receptors in the CNS. Nat Rev Neurosci17, 623–635, doi:nrn.2016.92 (2016). PubMed

Traynelis, S. F. et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev62, 405–496, doi:62/3/405 (2010). PubMed PMC

Mahfooz, K. et al. GluN3A promotes NMDA spiking by enhancing synaptic transmission in Huntington’s disease models. Neurobiol Dis93, 47–56, doi:S0969-9961(16)30074-2 (2016). PubMed

Marco, S. et al. Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington’s disease models. Nat Med19, 1030–1038, doi:nm.3246 (2013). PubMed PMC

Mueller, H. T. & Meador-Woodruff, J. H. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr Res71, 361–370, doi:S0920996404000908 (2004). PubMed

Yuan, T. et al. Expression of cocaine-evoked synaptic plasticity by GluN3A-containing NMDA receptors. Neuron80, 1025–1038, doi:S0896-6273(13)00709-5 (2013). PubMed

Chen, J. et al. Demonstration of critical role of GRIN3A in nicotine dependence through both genetic association and molecular functional studies. Addict Biol, 10.1111/adb.12718 (2019). PubMed

Lemke, J. R. et al. Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy. Neurology86, 2171–2178, doi:WNL.0000000000002740 (2016). PubMed PMC

Chen, W. et al. GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function. J Hum Genet, doi:jhg201719 (2017). PubMed PMC

Takata A, et al. A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biol Psychiatry. 2013;73:532–539. doi: 10.1016/j.biopsych.2012.10.024. PubMed DOI

Shen, Y. C. et al. Exomic sequencing of the ionotropic glutamate receptor N-methyl-D-aspartate 3A gene (GRIN3A) reveals no association with schizophrenia. Schizophr Res114, 25–32, doi:S0920-9964(09)00323-5 (2009). PubMed

Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci. 2013;14:383–400. doi: 10.1038/nrn3504. PubMed DOI

Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science. 1988;241:835–837. doi: 10.1126/science.2841759. PubMed DOI

Clements, J. D. & Westbrook, G. L. Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-D-aspartate receptor. Neuron7, 605–613, doi:0896-6273(91)90373-8 (1991). PubMed

Patneau DK, Mayer ML. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J Neurosci. 1990;10:2385–2399. doi: 10.1523/JNEUROSCI.10-07-02385.1990. PubMed DOI PMC

Awobuluyi, M. et al. Subunit-specific roles of glycine-binding domains in activation of NR1/NR3 N-methyl-D-aspartate receptors. Mol Pharmacol71, 112–122, doi:mol.106.030700 (2007). PubMed

Kvist, T., Greenwood, J. R., Hansen, K. B., Traynelis, S. F. & Brauner-Osborne, H. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors. Neuropharmacology75, 324–336, doi:S0028-3908(13)00360-2 (2013). PubMed PMC

Madry, C. et al. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function. Biochem Biophys Res Commun354, 102–108, doi:S0006-291X(06)02825-7 (2007). PubMed

Kehoe LA, Bernardinelli Y, Muller D. GluN3A: an NMDA receptor subunit with exquisite properties and functions. Neural Plast. 2013;2013:145387. doi: 10.1155/2013/145387. PubMed DOI PMC

Horak M, Petralia RS, Kaniakova M, Sans N. ER to synapse trafficking of NMDA receptors. Front Cell Neurosci. 2014;8:394. doi: 10.3389/fncel.2014.00394. PubMed DOI PMC

Sanz-Clemente, A., Nicoll, R. A. & Roche, K. W. Diversity in NMDA receptor composition: many regulators, many consequences. Neuroscientist19, 62–75, doi:1073858411435129 (2013). PubMed PMC

Hansen KB, Yi F, Perszyk RE, Menniti FS, Traynelis SF. NMDA Receptors in the Central Nervous System. Methods Mol Biol. 2017;1677:1–80. doi: 10.1007/978-1-4939-7321-7_1. PubMed DOI PMC

Chazot PL, Stephenson FA. Biochemical evidence for the existence of a pool of unassembled C2 exon-containing NR1 subunits of the mammalian forebrain NMDA receptor. J Neurochem. 1997;68:507–516. doi: 10.1046/j.1471-4159.1997.68020507.x. PubMed DOI

Huh KH, Wenthold RJ. Turnover analysis of glutamate receptors identifies a rapidly degraded pool of the N-methyl-D-aspartate receptor subunit, NR1, in cultured cerebellar granule cells. J Biol Chem. 1999;274:151–157. doi: 10.1074/jbc.274.1.151. PubMed DOI

Meddows E, et al. Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors. J Biol Chem. 2001;276:18795–18803. doi: 10.1074/jbc.M101382200. PubMed DOI

Schuler, T., Mesic, I., Madry, C., Bartholomaus, I. & Laube, B. Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-D-aspartate receptor assembly. J Biol Chem283, 37–46, doi:M703539200 (2008). PubMed

Atlason, P. T., Garside, M. L., Meddows, E., Whiting, P. & McIlhinney, R. A. N-Methyl-D-aspartate (NMDA) receptor subunit NR1 forms the substrate for oligomeric assembly of the NMDA receptor. J Biol Chem282, 25299–25307, doi:M702778200 (2007). PubMed

Farina, A. N. et al. Separation of domain contacts is required for heterotetrameric assembly of functional NMDA receptors. J Neurosci31, 3565–3579, doi:31/10/3565 (2011). PubMed PMC

McIlhinney RA, et al. Assembly intracellular targeting and cell surface expression of the human N-methyl-D-aspartate receptor subunits NR1a and NR2A in transfected cells. Neuropharmacology. 1998;37:1355–1367. doi: 10.1016/S0028-3908(98)00121-X. PubMed DOI

Perez-Otano, I. et al. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci21, 1228–1237, doi:21/4/1228 (2001). PubMed PMC

Standley, S., Roche, K. W., McCallum, J., Sans, N. & Wenthold, R. J. PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron28, 887–898, doi:S0896-6273(00)00161-6 (2000). PubMed

Okabe S, Miwa A, Okado H. Alternative splicing of the C-terminal domain regulates cell surface expression of the NMDA receptor NR1 subunit. J Neurosci. 1999;19:7781–7792. doi: 10.1523/JNEUROSCI.19-18-07781.1999. PubMed DOI PMC

Horak, M. & Wenthold, R. J. Different roles of C-terminal cassettes in the trafficking of full-length NR1 subunits to the cell surface. J Biol Chem284, 9683–9691, doi:M807050200 (2009). PubMed PMC

Hawkins LM, et al. Export from the endoplasmic reticulum of assembled N-methyl-d-aspartic acid receptors is controlled by a motif in the c terminus of the NR2 subunit. J Biol Chem. 2004;279:28903–28910. doi: 10.1074/jbc.M402599200. PubMed DOI

Qiu, S. et al. An endoplasmic reticulum retention signal located in the extracellular amino-terminal domain of the NR2A subunit of N-Methyl-D-aspartate receptors. J Biol Chem284, 20285–20298, doi:M109.004960 (2009). PubMed PMC

Matsuda, K., Fletcher, M., Kamiya, Y. & Yuzaki, M. Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors. J Neurosci23, 10064–10073, doi:23/31/10064 (2003). PubMed PMC

Washbourne P, Bennett JE, McAllister AK. Rapid recruitment of NMDA receptor transport packets to nascent synapses. Nat Neurosci. 2002;5:751–759. doi: 10.1038/nn883. PubMed DOI

Washbourne P, Liu XB, Jones EG, McAllister AK. Cycling of NMDA receptors during trafficking in neurons before synapse formation. J Neurosci. 2004;24:8253–8264. doi: 10.1523/JNEUROSCI.2555-04.2004. PubMed DOI PMC

Jeyifous O, et al. SAP97 and CASK mediate sorting of NMDA receptors through a previously unknown secretory pathway. Nat Neurosci. 2009;12:1011–1019. doi: 10.1038/nn.2362. PubMed DOI PMC

Groc L, et al. Differential activity-dependent regulation of the lateral mobilities of AMPA and NMDA receptors. Nat Neurosci. 2004;7:695–696. doi: 10.1038/nn1270. PubMed DOI

Dupuis, J. P. & Groc, L. Surface trafficking of neurotransmitter receptors: From cultured neurons to intact brain preparations. Neuropharmacology, doi:S0028-3908(19)30168-6 (2019). PubMed

Roche KW, et al. Molecular determinants of NMDA receptor internalization. Nat Neurosci. 2001;4:794–802. doi: 10.1038/90498. PubMed DOI

Perez-Otano I, et al. Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1/syndapin1. Nat Neurosci. 2006;9:611–621. doi: 10.1038/nn1680. PubMed DOI PMC

Lavezzari G, McCallum J, Dewey CM, Roche KW. Subunit-specific regulation of NMDA receptor endocytosis. J Neurosci. 2004;24:6383–6391. doi: 10.1523/JNEUROSCI.1890-04.2004. PubMed DOI PMC

Scott DB, Michailidis I, Mu Y, Logothetis D, Ehlers MD. Endocytosis and degradative sorting of NMDA receptors by conserved membrane-proximal signals. J Neurosci. 2004;24:7096–7109. doi: 10.1523/JNEUROSCI.0780-04.2004. PubMed DOI PMC

Kato, A., Rouach, N., Nicoll, R. A. & Bredt, D. S. Activity-dependent NMDA receptor degradation mediated by retrotranslocation and ubiquitination. Proc Natl Acad Sci USA102, 5600–5605, doi:0501769102 (2005). PubMed PMC

Fukaya M, Kato A, Lovett C, Tonegawa S, Watanabe M. Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum in targeted NR1 knockout mice. Proc Natl Acad Sci USA. 2003;100:4855–4860. doi: 10.1073/pnas.0830996100. PubMed DOI PMC

She, K., Ferreira, J. S., Carvalho, A. L. & Craig, A. M. Glutamate binding to the GluN2B subunit controls surface trafficking of N-methyl-D-aspartate (NMDA) receptors. J Biol Chem287, 27432–27445, doi:M112.345108 (2012). PubMed PMC

Kenny, A. V., Cousins, S. L., Pinho, L. & Stephenson, F. A. The integrity of the glycine co-agonist binding site of N-methyl-D-aspartate receptors is a functional quality control checkpoint for cell surface delivery. J Biol Chem284, 324–333, doi:M804023200 (2009). PubMed

Swanger, S. A. et al. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains. Am J Hum Genet99, 1261–1280, doi:S0002-9297(16)30438-4 (2016). PubMed PMC

Skrenkova K, et al. N-Glycosylation Regulates the Trafficking and Surface Mobility of GluN3A-Containing NMDA Receptors. Front Mol Neurosci. 2018;11:188. doi: 10.3389/fnmol.2018.00188. PubMed DOI PMC

Smothers, C. T. & Woodward, J. J. Expression of glycine-activated diheteromeric NR1/NR3 receptors in human embryonic kidney 293 cells Is NR1 splice variant-dependent. J Pharmacol Exp Ther331, 975–984, doi:jpet.109.158493 (2009). PubMed PMC

Cummings, K. A. & Popescu, G. K. Protons Potentiate GluN1/GluN3A Currents by Attenuating Their Desensitisation. Sci Rep6, 23344, doi:srep23344 (2016). PubMed PMC

Williams K, Chao J, Kashiwagi K, Masuko T, Igarashi K. Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit. Mol Pharmacol. 1996;50:701–708. PubMed

Weiss JN. The Hill equation revisited: uses and misuses. FASEB J. 1997;11:835–841. doi: 10.1096/fasebj.11.11.9285481. PubMed DOI

Grand T, Abi Gerges S, David M, Diana MA, Paoletti P. Unmasking GluN1/GluN3A excitatory glycine NMDA receptors. Nat Commun. 2018;9:4769. doi: 10.1038/s41467-018-07236-4. PubMed DOI PMC

Lichnerova K, Kaniakova M, Skrenkova K, Vyklicky L, Horak M. Distinct regions within the GluN2C subunit regulate the surface delivery of NMDA receptors. Front Cell Neurosci. 2014;8:375. doi: 10.3389/fncel.2014.00375. PubMed DOI PMC

Kaniakova, M. et al. 7-Methoxyderivative of tacrine is a ‘foot-in-the-door’ open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo. Neuropharmacology140, 217–232, doi:S0028-3908(18)30487-8 (2018). PubMed

Madry, C., Betz, H., Geiger, J. R. & Laube, B. Supralinear potentiation of NR1/NR3A excitatory glycine receptors by Zn2+ and NR1 antagonist. Proc Natl Acad Sci USA105, 12563–12568, doi:0805624105 (2008). PubMed PMC

Chatterton JE, et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 2002;415:793–798. doi: 10.1038/nature715. PubMed DOI

Yao, Y. & Mayer, M. L. Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A. J Neurosci26, 4559–4566, doi:26/17/4559 (2006). PubMed PMC

Rozeboom, A. M. et al. Evidence for glycinergic GluN1/GluN3 NMDA receptors in hippocampal metaplasticity. Neurobiol Learn Mem125, 265–273, doi:S1074-7427(15)00185-9 (2015). PubMed

Penn, A. C., Williams, S. R. & Greger, I. H. Gating motions underlie AMPA receptor secretion from the endoplasmic reticulum. EMBO J27, 3056–3068, doi:emboj2008222 (2008). PubMed PMC

Berger SJ, Carter JC, Lowry OH. The distribution of glycine, GABA, glutamate and aspartate in rabbit spinal cord, cerebellum and hippocampus. J Neurochem. 1977;28:149–158. doi: 10.1111/j.1471-4159.1977.tb07720.x. PubMed DOI

Meeker RB, Swanson DJ, Hayward JN. Light and electron microscopic localization of glutamate immunoreactivity in the supraoptic nucleus of the rat hypothalamus. Neuroscience. 1989;33:157–167. doi: 10.1016/0306-4522(89)90318-7. PubMed DOI

Wang W, et al. Glycine metabolism in animals and humans: implications for nutrition and health. Amino Acids. 2013;45:463–477. doi: 10.1007/s00726-013-1493-1. PubMed DOI

Moroni F, Russi P, Lombardi G, Beni M, Carla V. Presence of kynurenic acid in the mammalian brain. J Neurochem. 1988;51:177–180. doi: 10.1111/j.1471-4159.1988.tb04852.x. PubMed DOI

Yang, J. et al. The contribution of rare and common variants in 30 genes to risk nicotine dependence. Mol Psychiatry20, 1467–1478, doi:mp2014156 (2015). PubMed PMC

Lichnerova, K. et al. Two N-glycosylation Sites in the GluN1 Subunit Are Essential for Releasing N-methyl-d-aspartate (NMDA) Receptors from the Endoplasmic Reticulum. J Biol Chem290, 18379–18390, doi:M115.656546 (2015). PubMed PMC

Kaniakova, M. et al. Key amino acid residues within the third membrane domains of NR1 and NR2 subunits contribute to the regulation of the surface delivery of N-methyl-D-aspartate receptors. J Biol Chem287, 26423–26434, doi:M112.339085 (2012). PubMed PMC

Kaniakova M, Lichnerova K, Vyklicky L, Horak M. Single amino acid residue in the M4 domain of GluN1 subunit regulates the surface delivery of NMDA receptors. J Neurochem. 2012;123:385–395. doi: 10.1111/jnc.12002. PubMed DOI

Subunit-Dependent Surface Mobility and Localization of NMDA Receptors in Hippocampal Neurons Measured Using Nanobody Probes

The Extracellular Domains of GluN Subunits Play an Essential Role in Processing NMDA Receptors in the ER

Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists

The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors